TY - JOUR T1 - Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic JF - Frontline Gastroenterology JO - Frontline Gastroenterol SP - 77 LP - 81 DO - 10.1136/flgastro-2021-101805 VL - 13 IS - 1 AU - Shahida Din AU - Daniel Gaya AU - Jochen Kammermeier AU - Christopher A Lamb AU - Jonathan Macdonald AU - Gordon Moran AU - Gareth Parkes AU - Richard Pollok AU - Shaji Sebastian AU - Jonathan Segal AU - Christian Selinger AU - Philip J Smith AU - Helen Steed AU - Ian D Arnott Y1 - 2022/01/01 UR - http://fg.bmj.com/content/13/1/77.abstract N2 - The COVID-19 pandemic disrupted healthcare services across the world with only essential care being continued.1 2 For paediatric and adult patients with inflammatory bowel disease (IBD), this resulted in significant changes to accessing health services. In some services, IBD advice lines were stopped, specialist nurses and medical staff were redeployed to support acute admissions, outpatient clinics were deferred, and home care services were under threat.3 4 In addition, there was a reluctance from patients to come to hospital or contact their services due to concerns over their personal safety.5 6 The Crohn's and Colitis United Kingdom (CCUK) ‘life in lockdown’ patient survey reported that patients felt their IBD teams kept them well informed of coronavirus and their condition. Importantly, one in five patients reported that they also received inaccurate information on other aspects such as shielding.7 The pandemic has also highlighted the disparities in accessing healthcare8 and addressing these alongside organisational transformation will support personalised care, which is one of the main recommendations of the Inflammatory Bowel Disease United Kingdom (IBD UK) standards.9 Healthcare services have restarted routine clinical practices responding swiftly to regional and national lockdowns in the second wave.10 Additionally, local data have allowed clinical teams to refine service delivery supporting those most vulnerable to poorer outcomes if they develop COVID-19.11 12 The British Society of Gastroenterology (BSG) has commissioned independent reviews on the redesign of outpatient services focusing on telemedicine and restarting endoscopy safely.13–20 The COVID-19 pandemic effect on clinical research and trial activity are being addressed separately by the BSG IBD research committee.1 21 We are currently in our second wave of the pandemic and a third national lockdown with increasing pressure to maintain specialist services as well as directly supporting care for patients with COVID-19. … ER -